MIRDOT-50 ER
MRP: 3,500
Packaging: 10x1x10
Pack Type: tablet
Composition:
Mirabegron Extended Release 50mg
Indication:
Helps in Symptoms of Urgency, Urinary Incontinence and Urinary Frequency
Description:
Mirabegron 50 mg Extended Release is a beta-3 adrenergic receptor agonist used in the treatment of overactive bladder (OAB). It works by relaxing the detrusor smooth muscle during the storage phase of the urinary bladder fill-void cycle. This increases bladder capacity, reducing symptoms such as urinary urgency, frequency, and urge incontinence. The extended-release formulation ensures sustained activity with once-daily dosing.
Tags:
- Relieves symptoms of overactive bladder
- Reduces urinary urgency and frequent urination
- Helps control urge urinary incontinence
- Improves quality of life and bladder function
- Once-daily extended-release formula for consistent control
Usage Information
Dosage
Adults: 50 mg once daily, taken with or without food Tablets should be swallowed whole with water; do not crush or chew Dose adjustments may be required for patients with renal or hepatic impairment
Side Effects
Common: Increased blood pressure, headache, dry mouth, constipation Less common: Urinary tract infection, palpitations, back pain Rare: Allergic reactions, severe hypertension
Contraindications
Uncontrolled hypertension (≥180/110 mmHg) Known hypersensitivity to mirabegron or excipients Severe renal or hepatic impairment without dose adjustment Pediatric use not established
Availability
mirabegron 50 mg tablets, overactive bladder treatment, bladder control medicine, mirabegron ER, urinary urgency control, beta-3 agonist bladder